Sean Kevlahan, with a PhD in Chemical Engineering, is a seasoned product-driven entrepreneur. He co-founded and leads Nanite after propelling Quad Technologies from inception to a lucrative acquisition by Bio-Techne in 2018. His leadership of Bio-Techne's cell and gene therapy division through 2021 exemplifies his drive to transform biotech innovations into real solutions. Sean is compelled to solve complex ‘last mile’ challenges for cell and gene therapy.

Shashi Murthy, with a PhD in polymer science from MIT, is a recovering academic and co-founder of Quad Technologies. He also founded Flaskworks, where he pioneered complex high-throughput screening and biotech automation workflows. His work bridges engineering and biotechnology and led to the acquisition of Quad (Bio-Techne) and Flaskworks (Northwest Bio). Shashi is committed to shaping the future of industrial biotech innovation.

Thomas Neenan, with a PhD in the chemistry of materials, has spent his career exploring the boundaries between materials science and biology, generally in an entrepreneurial setting. Recent adventures include co-founding Panbela Therapeutics (NASDAQ: PBLA) and AbFero Pharmaceuticals (acquired by Pharmacosmos). Thomas is convinced of the potential of materials science to solve some of the most difficult questions in genetic medicine.

Felipe Oviedo, PhD, is an MIT-educated scientist working at the interface of materials science and artificial intelligence. Previously, while at Microsoft and CERN, he worked on AI applied to scientific and engineering problems. Throughout his career, Felipe has been at the forefront of the fusion of machine learning with materials science and biology, leading to novel insights in computation-driven therapeutics design.